Merger Preferences of Nuvilex Inc (OTCBB:NVLX)

Repost This

Las Vegas, NV -- (SBWIRE) -- 09/04/2013 -- Nuvilex Inc (OTCBB:NVLX) states that the young pharmaceutical companies are better to acquire since they have smaller R&D budgets. These younger firms are better in terms of offering return on investment.

Nuvilex says that these younger firms are also better than starting new business from the start since it requires a lot of market research. This shows that the company is in the mood to invest in younger companies.

The spending in younger companies is common recently. The company is also pursuing growth and investment opportunities.

Nuvilex, Inc. is a biotechnology company that explores derived products that improving the health and well-being of cancer patients. The company produces Cinnergen, Infinitink, Cinnechol, and Talysn Scar Cream. The Company works on Oraphyte which is non-toxic, biodegradable nematocide.

To find out what ChartPoppers projects for Nuvilex Inc for both short term and long term please click here: NVLX

ChartPoppers Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit ChartPoppers right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly ChartPoppers is the hottest thing in Hot Stocks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical., nor any of its affiliates are not registered investment advisors or broker dealers.